ONYCHOMYCOSIS DRUG EFFICACY BASED ON CLINICAL ENDPOINTS, NOT MYCOLOGICAL CULTURING OF NAIL FUNGUS, IS ACCEPTABLE FOR APPROVAL, FDA COMMITTEE CONCLUDES

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".